| Income Statement | Dec2023 |
|---|---|
| Revenue & cost | |
| Revenue | 2.00M |
| Operating items | |
| Research & Development | 19.78M |
| Selling, General & Administrative | 12.96M |
| Operating Expenses | 32.74M |
| Operating Income | -30.74M |
| EBIT | -30.74M |
| Non-operating items | |
| Interest & Investment Income | 2.86M |
| Other Non Operating Income | 2.86M |
| Non Operating Income | 2.86M |
| Net income details | |
| EBT | -27.88M |
| Profit After Tax | -27.88M |
| Income from Continuing Operations | -27.88M |
| Consolidated Net Income | -27.88M |
| Income towards Parent Company | -27.88M |
| Net Income towards Common Stockholders | -27.88M |
| Additional items | |
| EPS (Basic) | -2.66 |
| EPS (Weighted Average and Diluted) | -2.66 |
| Shares Outstanding (Weighted Average) | 22.90M |
| Shares Outstanding (Diluted Average) | 10.46M |
| EBITDA | -27.76M |